Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2019.25.6.697
Abstract: BACKGROUND The treatment for hepatitis C virus (HCV) infection has evolved over time, and direct-acting antivirals (DAA) have revolutionized HCV therapy. OBJECTIVES To (a) assess early treatment discontinuation and (b) identify predictors of early discontinuation… read more here.
Keywords: sim sof; early discontinuation; direct acting; discontinuation ... See more keywords